High-sensitivity C-reactive protein and erythrocyte sedimentation rate in systemic lupus erythematosus

Lupus

Volumn 20, Issue 6, 2011, Pages 588-597

  Firooz, N ^a,c   Albert, D A ^b   Wallace, D J ^a   Ishimori, M ^a   Berel, D ^a   Weisman, M H ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^c Medical Specialties   (United States)

Author keywords

erythrocyte sedimentation rate; high sensitivity C reactive protein; systemic lupus erythematosus

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; C REACTIVE PROTEIN; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; HYDROXYCHLOROQUINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INFLIXIMAB; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; ORAL CONTRACEPTIVE AGENT; PREDNISONE; RITUXIMAB;

ADULT; ARTICLE; BACTERIUM CULTURE; BLOOD; BLOOD VESSEL; CONTROLLED STUDY; DISEASE EXACERBATION; ELECTRONIC MEDICAL RECORD; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GASTROINTESTINAL TRACT; HEART; HORMONE SUBSTITUTION; HOSPITALIZATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; INFLAMMATION; JOINT; KIDNEY; LUNG; MAJOR CLINICAL STUDY; MALE; MUSCLE; NERVOUS SYSTEM; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SKIN; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; FEMALE; HUMANS; INTERLEUKIN-6; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SEROSITIS; YOUNG ADULT;

EID: 79956159584     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203310393378     Document Type: Article

References (60)

1. Ganapathi MK, Rzewnicki D, Samols D, Jiang SL, Kushner I. Effect of combinations of cytokines and hormones on synthesis of serum amyloid A and C-reactive protein in Hep 3B cells. J Immunol. 1991 ; 147: 1261-1265
2. Pereira Da Silva JA, Elkon KB, Hughes GR, Dyck RF, Pepys MB. C-reactive protein levels in systemic lupus erythematosus: a classification criterion?. Arthritis Rheum. 1980 ; 23: 770-771 (Pubitemid 10064911)
3. Coste J, Spira A, Clerc D, Paolaggi JB. Prediction of articular destruction in rheumatoid arthritis: disease activity markers revisited. J Rheumatol. 1997 ; 24: 28-34 (Pubitemid 27060703)
4. Wolfe F. Comparative usefulness of C-reactive protein and erythrocyte sedimentation rate in patients with rheumatoid arthritis. J Rheumatol. 1997 ; 24: 1477-1485 (Pubitemid 27320685)
5. Cantini F, Salvarani C, Olivieri I. Erythrocyte sedimentation rate and C-reactive protein in the diagnosis of polymyalgia rheumatica. Ann Intern Med. 1998 ; 128: 873-874 (Pubitemid 28267727)
6. Hill AG. C-reactive protein in the chronic rheumatic diseases. Lancet. 1951 ; 2: 807-811
7. Honig S, Gorevic P, Weissmann G. C-reactive protein in systemic lupus erythematosus. Arthritis Rheum. 1977 ; 20: 1065-1070
8. Becker GJ, Waldburger M, Hughes GR, Pepys MB. Value of serum C-reactive protein measurement in the investigation of fever in systemic lupus erythematosus. Ann Rheum Dis. 1980 ; 39: 50-52 (Pubitemid 10169236)
9. Pepys MB, Hirschfield GM, Tennent GA, et al. Targeting C-reactive protein for the treatment of cardiovascular disease. Nature. 2006 ; 440: 1217-1221
10. Hind CR, Ng SC, Feng PH, Pepys MB. Serum C-reactive protein measurement in the detection of intercurrent infection in Oriental patients with systemic lupus erythematosus. Ann Rheum Dis. 1985 ; 44: 260-261 (Pubitemid 15112840)
11. Bravo MG, Alarcon-Segovia D. C-reactive protein in the differential diagnosis between infection and disease reactivation in SLE. J Rheumatol. 1981 ; 8: 291-294 (Pubitemid 11073536)
12. ter Borg EJ, Horst G, Limburg PC, van Rijswijk MH, Kallenberg CG. C-reactive protein levels during disease exacerbations and infections in systemic lupus erythematosus: a prospective longitudinal study. J Rheumatol. 1990 ; 17: 1642-1648
13. Bertouch JV, Roberts-Thompson PJ, Feng PH, Bradley J. C-reactive protein and serological indices of disease activity in systemic lupus erythematosus. Ann Rheum Dis. 1983 ; 42: 655-658 (Pubitemid 14205431)
14. Koenig W, Sund M, Frohlich M, et al. C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation. 1999 ; 99: 237-242 (Pubitemid 29056365)
15. Danesh J, Wheeler JG, Hirschfield GM, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med. 2004 ; 350: 1387-1397 (Pubitemid 38419992)
16. Williams RC, Harmon ME, Burlingame R, Du Clos TW. Studies of serum C-reactive protein in systemic lupus erythematosus. J Rheumatol. 2005 ; 32: 454-461 (Pubitemid 40381415)
17. Tillett WS, Francis T. Serological reactions in pneumonia with a non-protein somatic fraction of pneumococcus. J Exp Med. 1930 ; 52: 561-571
18. In: Measuring immunity: basic biology and clinical assessment. Lotze MT Thompson AW, ed. Amsterdam: Elsevier Academic Press ; 2005: 135-135.
19. Ledue TB, Weiner DL, Sipe JD, Poulin SE, Collins MF, Rifai N. Analytical evaluation of particle-enhanced immunonephelometric assays for C-reactive protein, serum amyloid A and mannose-binding protein in human serum. Ann Clin Biochem. 1998 ; 35: 745-753 (Pubitemid 28523808)
20. Barnes EV, Narain S, Naranjo A, et al. High sensitivity C-reactive protein in systemic lupus erythematosus: relation to disease activity, clinical presentation and implications for cardiovascular risk. Lupus. 2005 ; 14: 576-582 (Pubitemid 41296993)
21. Suh CH, Jeong YS, Park HC, et al. Risk factors for infection and role of C-reactive protein in Korean patients with systemic lupus erythematosus. Clin Exp Rheumatol. 2001 ; 19: 191-194
22. al-Mekaimi A, Malaviya AN, Serebour F, et al. Serological characteristics of systemic lupus erythematosus from a hospital-based rheumatology clinic in Kuwait. Lupus. 1997 ; 6: 668-674 (Pubitemid 27480661)
23. Bertoli AM, Vila LM, Reveille JD, Alarcon GS. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): LXI. Value of C-reactive protein as a marker of disease activity and damage. J Rheumatol. 2008 ; 35: 2355-2358
24. Lee SS, Singh S, Link K, Petri M. High-sensitivity C-reactive protein as an associate of clinical subsets and organ damage in systemic lupus erythematosus. Semin Arthritis Rheum. 2008 ; 38: 41-54
25. Jackish JC, Somers E, McCune J American College of Rheumatology Annual Scientific Meeting. Washington DC: ; 2006: L22 - L22.
26. Bell SA, Faust H, Schmid A, Meurer M. Autoantibodies to C-reactive protein (CRP) and other acute-phase proteins in systemic autoimmune diseases. Clin Exp Immunol. 1998 ; 113: 327-332 (Pubitemid 28410554)
27. Sjowall C, Bengtsson AA, Sturfelt G, Skogh T. Serum levels of autoantibodies against monomeric C-reactive protein are correlated with disease activity in systemic lupus erythematosus. Arthritis Res Ther. 2004 ; 6: R87 - R94
28. Sjowall C, Wettero J. Pathogenic implications for autoantibodies against C-reactive protein and other acute phase proteins. Clin Chim Acta. 2007 ; 378: 13-23 (Pubitemid 46241084)
29. Vigushin DM, Pepys MB, Hawkins PN. Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease. J Clin Invest. 1993 ; 91: 1351-1357 (Pubitemid 23127332)
30. Marnell L, Mold C, Du Clos TW. C-reactive protein: ligands, receptors and role in inflammation. Clin Immunol. 2005 ; 117: 104-111 (Pubitemid 41407719)
31. Nijsten MW, de Groot ER, ten Duis HJ, Klasen HJ, Hack CE, Aarden LA. Serum levels of interleukin-6 and acute phase responses. Lancet. 1987 ; 2: 921-921
32. Gabay C, Roux-Lombard P, de Moerloose P, Dayer JM, Vischer T, Guerne PA. Absence of correlation between interleukin 6 and C-reactive protein blood levels in systemic lupus erythematosus compared with rheumatoid arthritis. J Rheumatol. 1993 ; 20: 815-821 (Pubitemid 23158475)
33. Russell AI, Cunninghame Graham DS, Shepherd C, et al. Polymorphism at the C-reactive protein locus influences gene expression and predisposes to systemic lupus erythematosus. Hum Mol Genet. 2004 ; 13: 137-147 (Pubitemid 38072141)
34. Swaak AJ, van Rooyen A, Aarden LA. Interleukin-6 (IL-6) and acute phase proteins in the disease course of patients with systemic lupus erythematosus. Rheumatol Int. 1989 ; 8: 263-268
35. Swaak AJ, van den Brink HG, Aarden LA. Cytokine production (IL-6 and TNF alpha) in whole blood cell cultures of patients with systemic lupus erythematosus. Scand J Rheumatol. 1996 ; 25: 233-238 (Pubitemid 26273854)
36. Peterson E, Robertson AD, Emlen W. Serum and urinary interleukin-6 in systemic lupus erythematosus. Lupus. 1996 ; 5: 571-575 (Pubitemid 27035726)
37. Hirohata S, Miyamoto T. Elevated levels of interleukin-6 in cerebrospinal fluid from patients with systemic lupus erythematosus and central nervous system involvement. Arthritis Rheum. 1990 ; 33: 644-649 (Pubitemid 20166565)
38. Linker-Israeli M, Deans RJ, Wallace DJ, Prehn J, Ozeri-Chen T, Klinenberg JR. Elevated levels of endogenous IL-6 in systemic lupus erythematosus. A putative role in pathogenesis. J Immunol. 1991 ; 147: 117-123
39. Lacki JK, Samborski W, Mackiewicz SH. Interleukin-10 and interleukin-6 in lupus erythematosus and rheumatoid arthritis, correlations with acute phase proteins. Clin Rheumatol. 1997 ; 16: 275-278 (Pubitemid 27273174)
40. Stuart RA, Littlewood AJ, Maddison PJ, Hall ND. Elevated serum interleukin-6 levels associated with active disease in systemic connective tissue disorders. Clin Exp Rheumatol. 1995 ; 13: 17-22
41. Chun HY, Chung JW, Kim HA, et al. Cytokine IL-6 and IL-10 as biomarkers in systemic lupus erythematosus. J Clin Immunol. 2007 ; 27: 461-466
42. Meijer C, Huysen V, Smeenk RT, Swaak AJ. Profiles of cytokines (TNF alpha and IL-6) and acute phase proteins (CRP and alpha 1AG) related to the disease course in patients with systemic lupus erythematosus. Lupus. 1993 ; 2: 359-365
43. Gaitonde S, Samols D, Kushner I. C-reactive protein and systemic lupus erythematosus. Arthritis Rheum. 2008 ; 59: 1814-1820
44. Mochizuki T, Aotsuka S, Satoh T. Clinical and laboratory features of lupus patients with complicating pulmonary disease. Respir Med. 1999 ; 93: 95-101 (Pubitemid 29062715)
45. Moutsopoulos HM, Mavridis AK, Acritidis NC, Avgerinos PC. High C-reactive protein response in lupus polyarthritis. Clin Exp Rheumatol. 1983 ; 1: 53-55 (Pubitemid 13049698)
46. Spronk PE, ter Borg EJ, Kallenberg CG. Patients with systemic lupus erythematosus and Jaccoud's arthropathy: a clinical subset with an increased C reactive protein response?. Ann Rheum Dis. 1992 ; 51: 358-361
47. Zuniga R, Markowitz GS, Arkachaisri T, Imperatore EA, D'Agati VD, Salmon JE. Identification of IgG subclasses and C-reactive protein in lupus nephritis: the relationship between the composition of immune deposits and FCgamma receptor type IIA alleles. Arthritis Rheum. 2003 ; 48: 460-470 (Pubitemid 36278015)
48. Brigden ML. Clinical utility of the erythrocyte sedimentation rate. Am Fam Physician. 1999 ; 60: 1443-1450 (Pubitemid 29498209)
49. Costenbader KH, Chibnik LB, Schur PH. Discordance between erythrocyte sedimentation rate and C-reactive protein measurements: clinical significance. Clin Exp Rheumatol. 2007 ; 25: 746-749 (Pubitemid 350284849)
50. Bedell SE, Bush BT. Erythrocyte sedimentation rate. From folklore to facts. Am J Med. 1985 ; 78: 1001-1009 (Pubitemid 15021266)
51. Ballou SK In: Kelly's textbook of rheumatology. Philadelphia, PA: Saunders Elsevier ; 2005: 720-727.
52. Brigden M. The erythrocyte sedimentation rate. Still a helpful test when used judiciously. Postgrad Med. 1998 ; 103: 257-262
53. Dilber E, Cakir M, Kalyoncu M, Okten A. C-reactive protein: a sensitive marker in the management of treatment response in parapneumonic empyema of children. Turk J Pediatr. 2003 ; 45: 311-314 (Pubitemid 38111295)
54. Khera A, McGuire DK, Murphy SA, et al. Race and gender differences in C-reactive protein levels. J Am Coll Cardiol. 2005 ; 46: 464-469 (Pubitemid 41040287)
55. Albert MA, Glynn RJ, Buring J, Ridker PM. C-reactive protein levels among women of various ethnic groups living in the United States (from the Women's Health Study). Am J Cardiol. 2004 ; 93: 1238-1242 (Pubitemid 38595677)
56. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. Elevated C-reactive protein levels in overweight and obese adults. JAMA. 1999 ; 282: 2131-2135
57. van Rooijen M, Hansson LO, Frostegard J, Silveira A, Hamsten A, Bremme K. Treatment with combined oral contraceptives induces a rise in serum C-reactive protein in the absence of a general inflammatory response. J Thromb Haemost. 2006 ; 4: 77-82
58. Cushman M, Legault C, Barrett-Connor E, et al. Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study. Circulation. 1999 ; 100: 717-722 (Pubitemid 29383641)
59. Ridker PM, Cannon CP, Morrow D, et al. C-reactive protein levels and outcomes after statin therapy. N Engl J Med. 2005 ; 352: 20-28 (Pubitemid 40075677)
60. Zonana-Nacach A, Barr SG, Magder LS, Petri M. Damage in systemic lupus erythematosus and its association with corticosteroids. Arthritis Rheum. 2000 ; 43: 1801-1808 (Pubitemid 30642567)